These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5606372)

  • 41. [Study of the therapeutic effectiveness and tolerability of the combination of tetracycline+trypsin + chymotrypsin as compared with tetracycline alone].
    Bosatra A; Russolo M
    Valsalva; 1971 Dec; 47(6):298-311. PubMed ID: 5147691
    [No Abstract]   [Full Text] [Related]  

  • 42. [Action of tetracycline-L-methacycline with trypsin-alphachymotrypsin in oral surgery].
    Arienza B
    Trib Odontol (B Aires); 1970; 54(1):15-7. PubMed ID: 5268836
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical evaluation of an enzyme-antibiotic treatment in dentistry using the "double-blind" method].
    Sabelli CA; Vita ME
    Rev Circ Argent Odontol; 1969 Aug; 32(3):41-8. PubMed ID: 5263550
    [No Abstract]   [Full Text] [Related]  

  • 44. Chemotherapy of tuberculosis for the 1980's.
    Dutt AK; Stead WW
    Prim Care; 1980 Sep; 7(3):513-27. PubMed ID: 7003628
    [No Abstract]   [Full Text] [Related]  

  • 45. [Significance of enzyme therapy with oral trypsin and chymotrypsin in chronic bronchial diseases in the course of inhalatory balneotherapy and of pulmonary ventilation].
    Lorenzini P
    Gazz Med Ital; 1965 Dec; 124(12):369-74. PubMed ID: 5860204
    [No Abstract]   [Full Text] [Related]  

  • 46. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract]   [Full Text] [Related]  

  • 47. [Parenteral administration of combined trypsin-chymtrypsin for the treatment of inflammatory gynecological conditions].
    DESTRO F; GREGORIG M
    Riv Ostet Ginecol Prat; 1959 May; 41(5):443-73. PubMed ID: 13675724
    [No Abstract]   [Full Text] [Related]  

  • 48. [Trypsin and chymotrypsin].
    Dobrescu D
    Med Interna (Bucur); 1965 Sep; 17(9):1123-6. PubMed ID: 5843761
    [No Abstract]   [Full Text] [Related]  

  • 49. Combined therapy with isoniazid and ethionamide in ulcero-caseous tuberculosis.
    Cornea P; Nisim F; Nicoulescu F
    Ther Hung; 1966; 14(1):24-9. PubMed ID: 5946507
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K
    Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simplified isoniazid acetylator phenotyping.
    Russell DW; Eidus L
    Can Med Assoc J; 1972 Jun; 106(11):1155-6. PubMed ID: 5034694
    [No Abstract]   [Full Text] [Related]  

  • 52. [Results of the use of an oral trypsin-chymotrypsin combination in gynecologic therapy].
    Tozzi T; Lauda N
    Minerva Ginecol; 1972; 24(8):405-9. PubMed ID: 4603804
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical aspects and outcome of recurrent pulmonary tuberculosis].
    Krasnov VA; Potashova VA; Zyrianova TV; Naryshkina SL
    Probl Tuberk; 1993; (5):14-6. PubMed ID: 8295875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
    Moulding TS; Le HQ; Rikleen D; Davidson P
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):743-8. PubMed ID: 15182145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Results of controlled clinical trials of intensive isoniazid therapy].
    Utkin VV; Keleberda KIa; Karachunskiĭ MA
    Probl Tuberk; 1980 Jul; (7):22-7. PubMed ID: 6997866
    [No Abstract]   [Full Text] [Related]  

  • 57. [Results of a study carried out in Morocco on intermittent treatment of pulmonary tuberculosis with a bi-weekly combination of isoniazid and streptomycin adminisrered intramuscularly].
    Burzoni FJ; Durante C
    Bull Int Union Tuberc; 1968 Dec; 41():322-4. PubMed ID: 5710256
    [No Abstract]   [Full Text] [Related]  

  • 58. [Reasons for failures in chemotherapy of tuberculosis].
    Dissmann E
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 138(1):17-24. PubMed ID: 5728639
    [No Abstract]   [Full Text] [Related]  

  • 59. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
    González Montaner LJ; Palma Beltrán O; Abbate E; Dambrosi A; Mosca C
    Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
    [No Abstract]   [Full Text] [Related]  

  • 60. [Isoniazid pharmacokinetics in the combined chemotherapy of tuberculosis].
    Sokolova GB; Vilenskaia RN; Ivleva AIa; Galenko NN; Ziia AV
    Probl Tuberk; 1981 Oct; (10):24-8. PubMed ID: 7312844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.